Navigation Links
Ranbaxy Gets FDA Approval for Hypertension Drug

Indian pharma major Ranbaxy Laboratories Limited has received the approval from the US Food and Drug //Administration (FDA) to manufacture and market generic hypertension drug Atenolol in the country.

Ranbaxy plans to market Atenolol tablets of 25 mg, 50 mg, and 100 mg dosage manufactured by Mumbai-based Ipca Laboratories in the US from the first quarter of 2007, the company said in a statement Tuesday.

Ipca Laboratories has an arrangement with Ranbaxy's wholly owned Florida-based subsidiary Ranbaxy Pharmaceuticals Inc (RPI) for marketing its products in the US.

"The Office of Generic Drugs of the US Food and Drug Administration, has determined the Ranbaxy formulations to be bioequivalent and have the same therapeutic effect as that of the reference listed drug Tenormin of AstraZeneca LP," Ranbaxy said.

Atenolol is indicated in the management of hypertension. It may be used alone or concomitantly with other anti-hypertensive agents, particularly with a thiazide-type diuretic.

"We are pleased to receive this final FDA approval to market Atenolol tablets. This will further expand our product portfolio of affordable generic alternatives to the brand in the treatment of cardiovascular disorders," said Jim Meehan, vice president (sales and marketing) for Ranbaxy Pharmaceuticals Inc.

"This approval is the result of a strategic alliance with Ipca Laboratories that will develop a number of generic prescription pharmaceutical products which will be marketed by RPI in the US," he added.

Source-IANS
'"/>




Page: 1

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy gets US FDA approval for Lisinopril
3. Ranbaxy Labs Entry Into Anti-Acne Market
4. Ranbaxy trying to make inroads in herbal drugs market
5. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
6. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
7. Ranbaxy opens Drug discovery centre in Gurgaon
8. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
9. SRL Ranbaxy offers quicker bird flu diagnostic test
10. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
11. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... 2017 , ... Peoples Health is pleased to announce that ... 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, serves more than 55,000 ... our provider network, and the addition will benefit our members in the Greater ...
(Date:1/17/2017)... NJ (PRWEB) , ... January 17, 2017 , ... Neil ... and financial planning assistance to communities throughout the region, is launching a charity drive ... Heart disease is by far the deadliest killer in America, and is responsible for ...
(Date:1/17/2017)... ... January 17, 2017 , ... Seceon ... cyber threats in real-time, today announced a strategic partnership with TechLab Security, ... Joining other Seceon partners, TechLab Security has become a strategic partner and a ...
(Date:1/17/2017)... CA (PRWEB) , ... January 17, 2017 , ... Many people make New Year’s resolutions ... Robert Mondavi is making it easier for people who want to kick off ... both new and existing patients. , These special offers include: , ...
(Date:1/16/2017)... ... January 17, 2017 , ... Recently, patients and staff ... Michigan, joined other volunteers and organizations in support of the annual Binder Park Zoo ... families dressed up in colorful costumes of all designs coming out to enjoy games, ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Calif. , Jan. 17, 2017  Edwards Lifesciences ... in patient-focused innovations for structural heart disease and critical ... the quarter ended December 31, 2016 after the market ... a conference call at 5:00 p.m. ET that day ... the conference call, dial (877) 407-8037 or (201) 689-8037.  ...
(Date:1/17/2017)... PUNE, India , Jan. 17, 2017  Market Research Future ... Global Endoscopy Devices Market is expected to reach USD 33.6 million ... 2016. Market Highlights ... The Global Endoscopy Devices Market has been examined as ... rate. Globally there is huge demand for endoscopy device in various ...
(Date:1/17/2017)... Research and Markets has announced the addition of the ... offering. ... global fluoropolymer market in the healthcare industry to grow at a ... Fluoropolymer Market in the Healthcare Industry 2016-2020, has been prepared based ... report covers the market landscape and its growth prospects over the ...
Breaking Medicine Technology: